LACK OF SELECTIVE V-BETA DELETION IN CD4+ OR CD8+ T-LYMPHOCYTES AND FUNCTIONAL INTEGRITY OF T-CELL REPERTOIRE DURING ACUTE HIV SYNDROME

被引:18
作者
COSSARIZZA, A
ORTOLANI, C
MUSSINI, C
GUARALDI, G
MONGIARDO, N
BORGHI, V
BARBIERI, D
BELLESIA, E
FRANCESCHINI, MG
DERIENZO, B
FRANCESCHI, C
机构
[1] SS GIOVANNI & PAOLO HOSP, DEPT CLIN PATHOL, VENICE, ITALY
[2] UNIV MODENA, SCH MED, DEPT INFECT DIS, I-41100 MODENA, ITALY
关键词
HIV; AIDS; ACUTE HIV SYNDROME; CYTOKINES; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA; CD45; CELL ADHESION MOLECULES; V-BETA T-CELL RECEPTOR; T-CELL REPERTOIRE;
D O I
10.1097/00002030-199506000-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the V beta T-cell repertoire in peripheral blood lymphocytes (PBL) during acute HIV syndrome by using several anti-V beta monoclonal antibodies (MAb) and to analyse its functionality by stimulating PBL with superantigens (SAg) such as Staphylococcus aureus enterotoxins. Methods: Cytofluorimetric analysis of V beta T-cell-receptor expression was performed on PBL from eight patients with symptomatic, acute HIV-1 primary infection, showing a dramatic decrease of CD4+ PBL accompanied by a marked increase in activated/memory CD8+ T cells, and on 12 age- and sex-matched healthy controls. PBL were then isolated, stimulated with different SAg, anti-CD3 MAb or phytohaemagglutinin and cultured for 3 days. PBL capability to progress through cell cycle was studied by the classic cytofluorimetric method of bromodeoxyuridine incorporation and DNA staining with propidium iodide. Results: Despite the presence of a few expansions of some V beta families among CD8+ T lymphocytes, no gross alterations in T-cell repertoire were present in patients with acute HIV syndrome. Its functionality was maintained overall, as PBL responsiveness to SAg was well preserved. Interestingly, all CD8+ T cells, although bearing different V beta T-cell receptors, expressed marked signs of activation, i.e., CD45R0, CD38 and major histocompatibility complex class II molecules, and also high amounts of CD11a and CD18. Conclusions: Our data suggest, at least in the early phases and in the acute form of the infection, that HIV is not likely to act as a SAg. However, further studies are needed to analyse other sites, such as lymph nodes, where HIV could exert other, significant effects, and to study the expression of other V beta families than those investigated here.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 70 条
  • [1] Fauci A.S., The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis, Science, 239, pp. 617-622, (1988)
  • [2] Blattner W., Gallo R.C., Temin H.M., HIV causes AIDS, Science, 241, pp. 515-516, (1988)
  • [3] Cooper D.A., Gold J., Maclean P., Et al., Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion, Lancet, 1, pp. 537-540, (1985)
  • [4] Tindall B., Cooper D.A., Primary HIV infection: Host responses and intervention strategies, AIDS, 5, pp. 1-14, (1991)
  • [5] Kessler H.A., Blaauw B., Spear J., Paul D.A., Falk L.A., Landay A., Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome, JAMA, 258, pp. 1196-1199, (1987)
  • [6] Rosenberg Z.F., Fauci A.S., Immunopathogenesis of HIV infection, FASEB J, 5, pp. 2382-2390, (1991)
  • [7] Breen A.C., Rezai A.R., Nakajima K., Et al., Infection with HIV is associated with elevated IL-6 levels and production, J Immunol, 144, pp. 480-484, (1990)
  • [8] Rautonen J., Rautonen N., Martin N.L., Philip R., Wara D.W., Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor α and immunoglobulin G and a concentrations in children with HIV infection, AIDS, 5, pp. 1319-1325, (1991)
  • [9] Gupta K.K., Acute immunosuppression with HIV seroconversion, N Engl J Med, 328, pp. 228-229, (1993)
  • [10] Pedersen C., Dickmeiss E., Gaub J., Et al., T-cell subset alterations and lymphocyte responsiveness to mitogen and antigen during severe primary infection with HIV: A case of seven consecutive HIV seroconverters, AIDS, 4, pp. 523-526, (1990)